检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘凤莲[1] 何凤屏[1] 高凌俊[2] 徐新[2] 马绍椿[2] 马占忠[1]
机构地区:[1]汕头大学医学院附属粤北人民医院检验科,广东省韶关市512026 [2]汕头大学医学院附属粤北人民医院心内科,广东省韶关市512026
出 处:《实用医学杂志》2013年第12期1927-1929,共3页The Journal of Practical Medicine
基 金:广东省自然基金资助项目(编号:9151008901000039);韶关市科技计划项目(编号:韶科[2012]38号)
摘 要:目的:探讨脂联素、LOX-1与原发性高血压发生、发展的关系。方法:收集120例原发性高血压患者,根据血压水平分组,高血压1级(37例),2级(40例),3级43例,同时选取健康对照40例。于肘静脉采血,采用ELISA法检测血浆脂联素及sLOX-1浓度,同时检测相关生化指标。结果:1、2、3级组脂联素水平均低于健康对照组,且3级组脂联素水平明显低于1级组(P<0.01);相反,1、2、3级组sLOX-1的水平均高于对照组,且3级组LOX-1水平明显高于1级组(P<0.01);血浆脂联素和sLOX-1水平呈显著负相关(r=-0.903,P<0.05)。结论:原发性高血压的发病与血浆脂联素及sLOX-1水平有密切关系。Objective To investigate the relations between adiponectin, LOX-1 and the development of essential hypertension. Methods 120 patients with essential hypertension were divided into 3 groups according to the levels of blood pressure : hypertension grade 1,2,3 groups with 37,40, and 43 cases, respectively ; another 40 normal controls as control group. Peripheral blood samples were collected from cubital vein, and the plasma concentrations of adiponectin and LOX-1 were measured by ELISA technique, and also the related biochemical indicators were tested. Results The plasma levets of adiponectin in hypertension grade 1,2,3 groups were significantly lower than that in control group, and that in hypertension grade 3 group was lower than that in hypertension grade 1 group (P 〈 0.01 ). The plasma levels of LOX-1 in hypertension grade 1,2,3 groups were significantly higher than that in control group, and that in hypertension grade 3 group was higher than that in hypertension grade 1 group (P 〈 0.01 ). Plasma level of LOX-I was negatively correlated with adiponectin (r = -0.903, P 〈 0.05). Conclusion Plasma levels of LOX-1 and adiponectin were closely related to essential hypertension.
分 类 号:R544.1[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.237